BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33753837)

  • 21. Stroke and transient ischemic attack incidence rate in Spain: the IBERICTUS study.
    Díaz-Guzmán J; Egido JA; Gabriel-Sánchez R; Barberá-Comes G; Fuentes-Gimeno B; Fernández-Pérez C;
    Cerebrovasc Dis; 2012; 34(4):272-81. PubMed ID: 23095851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NT-pro-BNP: A novel predictor of stroke risk after transient ischemic attack.
    Rodríguez-Castro E; Hervella P; López-Dequidt I; Arias-Rivas S; Santamaría-Cadavid M; López-Loureiro I; da Silva-Candal A; Pérez-Mato M; Sobrino T; Campos F; Castillo J; Rodríguez-Yáñez M; Iglesias-Rey R
    Int J Cardiol; 2020 Jan; 298():93-97. PubMed ID: 31272739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of hs-CRP, D-dimer and fibrinogen in differentiating etiological subtypes of ischemic stroke.
    Liu LB; Li M; Zhuo WY; Zhang YS; Xu AD
    PLoS One; 2015; 10(2):e0118301. PubMed ID: 25680111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipids in ischemic stroke subtypes.
    Laloux P; Galanti L; Jamart J
    Acta Neurol Belg; 2004 Mar; 104(1):13-9. PubMed ID: 15143957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C-reactive protein is a determinant of first-ever stroke: prospective nested case-referent study.
    Andersson J; Johansson L; Ladenvall P; Wiklund PG; Stegmayr B; Jern C; Boman K
    Cerebrovasc Dis; 2009; 27(6):544-51. PubMed ID: 19390179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The importance of selected markers of inflammation and blood-brain barrier damage for short-term ischemic stroke prognosis.
    Lasek-Bal A; Jedrzejowska-Szypulka H; Student S; Warsz-Wianecka A; Zareba K; Puz P; Bal W; Pawletko K; Lewin-Kowalik J
    J Physiol Pharmacol; 2019 Apr; 70(2):. PubMed ID: 31356182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiplatelet therapy as a modulator of stroke aetiology: a meta-analysis.
    Rajkumar CA; Floyd CN; Ferro A
    Br J Clin Pharmacol; 2015 Sep; 80(3):331-41. PubMed ID: 25784356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum lipopolysaccharide neutralizing capacity in ischemic stroke.
    Leskelä J; Pietiäinen M; Safer A; Lehto M; Metso J; Malle E; Buggle F; Becher H; Sundvall J; Grau AJ; Pussinen PJ; Palm F
    PLoS One; 2020; 15(2):e0228806. PubMed ID: 32084157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences of circulating inflammatory markers between large- and small vessel disease in patients with acute ischemic stroke.
    Zeng L; He X; Liu J; Wang L; Weng S; Wang Y; Chen S; Yang GY
    Int J Med Sci; 2013; 10(10):1399-405. PubMed ID: 23983602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood C-reactive protein concentration with ABCD² is a better prognostic tool than ABCD² alone.
    Corso G; Bottacchi E; Brusa A; Lia C; Cordera S; Giardini G; Pesenti Campagnoni M; Veronese Morosini M
    Cerebrovasc Dis; 2011; 32(2):97-105. PubMed ID: 21709407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autonomic dysfunction in different subtypes of post-acute ischemic stroke.
    Xiong L; Leung HW; Chen XY; Leung WH; Soo OY; Wong KS
    J Neurol Sci; 2014 Feb; 337(1-2):141-6. PubMed ID: 24326200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipopolysaccharide binding protein, interleukin-6 and C-reactive protein in acute gastrointestinal infections: value as biomarkers to reduce unnecessary antibiotic therapy.
    Elsing C; Ernst S; Kayali N; Stremmel W; Harenberg S
    Infection; 2011 Aug; 39(4):327-31. PubMed ID: 21523403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma endotoxin activity rises during ischemic stroke and is associated with worse short-term outcome.
    Klimiec E; Pera J; Chrzanowska-Wasko J; Golenia A; Slowik A; Dziedzic T
    J Neuroimmunol; 2016 Aug; 297():76-80. PubMed ID: 27397079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular Risk Factors in Patients with Different Subtypes of Ischemic Stroke May Affect Their Outcome after Intravenous tPA.
    Dong Y; Cao W; Ren J; Nair DS; Parker S; Jahnel JL; Swanson-Devlin TG; Beck JM; Mathews M; McNeil CJ; Upadhyaya M; Gao Y; Dong Q; Wang DZ
    PLoS One; 2015; 10(8):e0131487. PubMed ID: 26247772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A retrospective study on early carotid endarterectomy within 48 hours after transient ischemic attack and stroke in evolution.
    Ferrero E; Ferri M; Viazzo A; Labate C; Berardi G; Pecchio A; Piazza S; Ripepi M; Nessi F
    Ann Vasc Surg; 2014 Jan; 28(1):227-38. PubMed ID: 24011816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved.
    Schröder NW; Morath S; Alexander C; Hamann L; Hartung T; Zähringer U; Göbel UB; Weber JR; Schumann RR
    J Biol Chem; 2003 May; 278(18):15587-94. PubMed ID: 12594207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C-reactive protein predicts further ischemic events in first-ever transient ischemic attack or stroke patients with intracranial large-artery occlusive disease.
    Arenillas JF; Alvarez-Sabín J; Molina CA; Chacón P; Montaner J; Rovira A; Ibarra B; Quintana M
    Stroke; 2003 Oct; 34(10):2463-8. PubMed ID: 14500938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in polymorphonuclear leukocyte surface and plasma bactericidal/permeability-increasing protein and plasma lipopolysaccharide binding protein during endotoxemia or sepsis.
    Calvano SE; Thompson WA; Marra MN; Coyle SM; de Riesthal HF; Trousdale RK; Barie PS; Scott RW; Moldawer LL; Lowry SF
    Arch Surg; 1994 Feb; 129(2):220-6. PubMed ID: 7508221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-LPS targets and actions of LPS binding protein (LBP).
    Schröder NW; Schumann RR
    J Endotoxin Res; 2005; 11(4):237-42. PubMed ID: 16176661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipopolysaccharide-binding protein and future Parkinson's disease risk: a European prospective cohort.
    Zhao Y; Walker DI; Lill CM; Bloem BR; Darweesh SKL; Pinto-Pacheco B; McNeil B; Miller GW; Heath AK; Frissen M; Petrova D; Sánchez MJ; Chirlaque MD; Guevara M; Zibetti M; Panico S; Middleton L; Katzke V; Kaaks R; Riboli E; Masala G; Sieri S; Zamora-Ros R; Amiano P; Jenab M; Peters S; Vermeulen R
    J Neuroinflammation; 2023 Jul; 20(1):170. PubMed ID: 37480114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.